We report herein a case of adult T-cell leukemia/lymphoma (ATLL), with the development of HBV reactivation-related hepatitis during chemotherapy for ATLL and successful treatment with a combination of entecavir and short-term administration of interferon (IFN)-β 3 MIU twice per day. This evidence concerns the gene PPIB and adult T-cell leukemia/lymphoma.